Prescribing Guidelines

Clozapine and Metabolic Monitoring

September 18, 2025

Indications for Taking Clozapine

September 18, 2025

California Department of State Hospitals Psychotropic Medication Operational Procedures (updated 11/13/2025)

September 2, 2025

Video Series: Maximizing Treatment Outcomes with Lithium

May 14, 2025

Prescribing Lithium

April 22, 2024

Sublocade (Suboxone)

March 11, 2024

Brixadi (Subutex)

March 11, 2024

Guidance for Missed Maintenance Doses for Long-acting Injectable Antipsychotics

September 23, 2021

APA’s Schizophrenia Treatment Guidelines – LAI Antipsychotics

October 16, 2020

Changing or switching a patient treated with LAI to Risperdal Consta (risperidone microspheres)

July 17, 2020

Changing or switching a patient from a different long-acting injectable medication (LAI) to Invega Sustenna (paliperidone palmitate)

May 4, 2020

Changing or switching a patient from a different long-acting injectable (LAI) antipsychotic medication to Aristada

April 22, 2020

Guidelines for the use and management of long-acting injectable antipsychotics in serious mental illness

March 13, 2020

Transitioning a patient from risperidone oral to paliperidone palmitate (Invega Sustenna)

March 6, 2020

Deltoid Injection Side Effect Relief

March 6, 2020

Changing or switching a patient from a different long acting injectable medication (LAI) to Abilify Maintena

February 25, 2020

What should clinicians know about Aristada (aripiprazole lauroxil LAI)?

January 23, 2020

Long-Acting Injectables: Pharmacological Information – LAI Table of Considerations

December 30, 2019

Long-acting injection antipsychotic medications in the management of schizophrenia (excerpt from APA Clinical Practice Guideline)

December 27, 2019

Establishing Tolerability

September 4, 2019